Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Cellular Physiology|January 3, 2013
Pin1 and nuclear receptors: a new language?Raffaele La Montagna, Isabella Caligiuri, Antonio Giordano, et al.
Journal of Cellular Biochemistry|September 30, 2008
Leptin signaling in breast cancer: an overviewDonatella Cirillo, Anna Maria Rachiglio, Raffaele la Montagna, et al.
Current Topics in Medicinal Chemistry|April 8, 2010
Adenosine receptor ligands in clinical trialsFlavio Rizzolio, Raffaele La Montagna, Tiziano Tuccinardi, et al.
Peptides|August 30, 2008
Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibioticsMarco Cassone, Paraskevi Vogiatzi, Raffaele La Montagna, et al.
International Journal of Cancer|April 10, 2009
The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cellsAlessandra Rossi, Giuseppe Russo, Andrew Puca, et al.
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Androgen receptor serine 81 mediates Pin1 interaction and activityRaffaele La Montagna, Isabella Caligiuri, Pasquale Maranta, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2010
New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cellsAlessandra Rossi, Silvia Schenone, Adriano Angelucci, et al.
Journal of Cellular Physiology|August 9, 2019
Genomic analysis reveals association of specific SNPs with athletic performance and susceptibility to injuries in professional soccer playersRaffaele La Montagna, Raffaele Canonico, Luigi Alfano, et al.
The Journal of Cell Biology|January 20, 2019
The activity of Sac1 across ER-TGN contact sites requires the four-phosphate-adaptor-protein-1Rossella Venditti, Maria Chiara Masone, Laura Rita Rega, et al.
Cancers|March 12, 2020
Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to CisplatinMarta Mariniello, Raffaella Petruzzelli, Luca G Wanderlingh, et al.
Pageof 1